A.Prof. Robert Wilcox
机构: Flinders Medical Centre, Flinders Uni & UniSA, Adelaide Australia
每年引用次数
引用次数
引用: 2,305
H-指数: 27
I10-指数 : 47
出版物: 99
INS(1,3,4,5)P(4)MOBILISES CA2+ STORES IN HUMAN SH-SY5Y NEUROBLASTOMA-CELLS - EVIDENCE FOR AN INTERACTION WITH INS(1,4,5)P(3) RECEPTORS
Challiss Raj. , Potter Bvl. , R A Wilcox , Nahorski
British Journal of Pharmacology 111
1994
Stereoselectivity of Ins(1,3,4,5)P4 recognition sites: implications for the mechanism of the Ins(1,3,4,5)P4-induced Ca2+ mobilization.
R A Wilcox , R A Challiss , G Baudin , A Vasella
Biochemical Journal 294 ( 1) 191 -194
28
1993
Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
R A Wilcox , R A Challiss , J R Traynor , A H Fauq
Journal of Biological Chemistry 269 ( 43) 26815 -26821
26
1994
Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes
Roland B. GREGORY , Rachael HUGHES , Andrew M. RILEY , Barry V. L. POTTER
Biochemical Journal 381 ( 2) 519 -526
12
2004
Stable overexpression of the type-1 inositol 1,4,5-trisphosphate receptor in L fibroblasts: subcellular distribution and functional consequences.
John J. MACKRILL , Robert A WILCOX , Atsushi MIYAWAKI , Katsuhiko MIKOSHIBA
Biochemical Journal 318 ( 3) 871 -878
22
1996
the myo-inositol-1, 4, 5-trisphosphate Receptor
ROBERT A WILCOX , CHRISTOPHE ERNEUX , WILLIAM U PRIMROSE , ROY GIGG
MOLECULAR PHARMACOLOGY AN INTERNATIONAL JOURNAL 47 1204 -1211
1995
Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate
Robert A. Wilcox , Emma.M. Whitham , Changsheng Liu , Barry V.L. Potter
FEBS Letters 336 ( 2) 267 -271
20
1993
Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor
Neil T. Burford , Stefan R. Nahorski , Sung-Kee Chung , Young-Tae Chang
Cell Calcium 21 ( 4) 301 -310
14
1997
Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene
Katja Lohmann , Robert A. Wilcox , Susen Winkler , Alfredo Ramirez
Annals of Neurology 73 ( 4) 537 -545
102
2013
Whispering dysphonia in an Australian family (DYT4): A clinical and genetic reappraisal
Robert A. Wilcox , Susen Winkler , Katja Lohmann , Christine Klein
Movement Disorders 26 ( 13) 2404 -2408
44
2011
Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control
Verity Pearson-Dennett , Patrick L. Faulkner , Brittany Collie , Robert A. Wilcox
Clinical Neurophysiology 130 ( 5) 655 -665
2
2019
Hand function is impaired in healthy older adults at risk of Parkinson’s disease
Gabrielle Todd , Miranda Haberfield , Patrick L. Faulkner , Caroline Rae
Journal of Neural Transmission 121 ( 11) 1377 -1386
3
2014
The Novel Ins(1,4,5)P3 Analog 3-Amino-3-deoxy-Ins(1,4,5)P3: A pH-Dependent Ins(1,4,5)P3 Receptor Partial Agonist in SH-SY5Y Neuroblastoma Cells
Alan P. Kozikowski , Abdul H. Fauq , Robert A. Wilcox , R. A. John Challiss
Journal of Medicinal Chemistry 37 ( 6) 868 -872
14
1994
Movement Dysfunction as a Neuropathology of Illicit Stimulant Abuse
Verity Pearson-Dennett , Robert A. Wilcox , Jason M. White , Gabrielle Todd
Neuropathology of Drug Addictions and Substance Misuse#R##N#Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions 219 -228
2016
History of cannabis use is associated with altered gait.
Verity Pearson-Dennett , Gabrielle Todd , Robert A. Wilcox , Adam P. Vogel
Drug and Alcohol Dependence 178 215 -222
6
2017
Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use
Gabrielle Todd , Lucinda Burns , Verity Pearson-Dennett , Adrian Esterman
Drug and Alcohol Dependence 205 107595 -107595
2019
1D-myo-inositol 1,4,5-trisphosphate and 1D-myo-inositol 1,3,4,5-tetrakisphosphate analogues modified at C-3; synthesis of 1D-3-C-(trifluoromethyl)-myo-inositol 1,4,5-trisphosphate and 1L-chiro-insitol 1,2,3,5-tetrakisphosphate from L-quebrachitol
Alan P. Kozikowski , Vassil I. Ognyanov , Abdul H. Fauq , Robert A. Wilcox
Journal of The Chemical Society, Chemical Communications ( 5) 599 -600
19
1994
Probing the D-1,4,5-IP3/D-1,3,4,5-IP4 functional interface. Synthesis and pharmacology of novel D-3-modified myo-inositol trisphosphate analogues
Abdul H. Fauq , Alan P. Kozikowski , Vassil I. Ognyanov , Robert A. Wilcox
Journal of The Chemical Society, Chemical Communications ( 11) 1301 -1302
10
1994
Hand Function is Altered in Individuals with a History of Illicit Stimulant Use
Verity Pearson-Dennett , Stanley C. Flavel , Robert A. Wilcox , Dominic Thewlis
PLOS ONE 9 ( 12)
6
2014
Defining the minimal structural requirements for partial agonism at the type I myo‐inositol 1,4,5‐trisphosphate receptor
Robert A. Wilcox , Abdul Fauq , Alan P. Kozikowski , Stefan R. Nahorski
FEBS Letters 402 ( 2) 241 -245
14
1997